Printability of pharmaceutical Fused Deposition Modeling (FDM) feedstock material : mechanical characterisation of FDM filaments and the FDM 3D printing process
Prasad, Elke and Robertson, John and Halbert, Gavin W. (2022) Printability of pharmaceutical Fused Deposition Modeling (FDM) feedstock material : mechanical characterisation of FDM filaments and the FDM 3D printing process. In: AAPS 2022 Pharm Sci 360, 2022-10-16 - 2022-10-19, USA.
Preview |
Text.
Filename: Prasad_etal_AAPS_2022_Printability_of_pharmaceutical_fused_deposition_modeling_FDM_feedstock_material.pdf
Final Published Version License: Download (748kB)| Preview |
Abstract
Purpose -- 3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers facilitates advanced control of the microstructure of the tablet core and therefore drug release properties. For this 3DP process an intermediate feedstock material is manufactured and used in the FDM process. However, mechanical and rheological properties of pharmaceutically approved polymers are often not suitable for this process. In order to identify suitable filaments for the FDM process, the objective of this study was to perform a mechanical and rheological characterisation of the feedstock material during an FDM process. Conclusions -- Mechanical properties of an FDM process for commercial and in-house prepared pharmaceutically relevant feed stock material were investigated and have shown the material dependant impact of print geometries and print speed on the FDM process; informing future development of pharmaceutically relevant feedstock material.
ORCID iDs
Prasad, Elke ORCID: https://orcid.org/0000-0002-5412-9374, Robertson, John ORCID: https://orcid.org/0000-0002-2191-1319 and Halbert, Gavin W.;-
-
Item type: Conference or Workshop Item(Poster) ID code: 83820 Dates: DateEvent16 October 2022PublishedSubjects: Medicine > Pharmacy and materia medica > Pharmaceutical technology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences > Continuous Manufacturing and Crystallisation
Technology and Innovation Centre > Continuous Manufacturing and Crystallisation (CMAC)Depositing user: Pure Administrator Date deposited: 25 Jan 2023 09:43 Last modified: 11 Nov 2024 17:08 URI: https://strathprints.strath.ac.uk/id/eprint/83820